Kevin J. Ontiveros
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Kevin J. Ontiveros
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 27 | |
| Public Company | Medical Specialties | 18 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kevin J. Ontiveros
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| CAMBREX CORPORATION | Pharmaceuticals: Generic | Director/Board Member | |
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| LADRX CORPORATION | Biotechnology | Chairman | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
| COVANCE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Corange Ltd.
 Corange Ltd. Pharmaceuticals: GenericHealth Technology Part of Roche Holding AG, Corange Ltd. is a Bermudian company that manufactures orthopedic and diagnostics equipment. The company is based in Hamilton, Bermuda. Corange was acquired by Roche Holding AG on May 01, 1997 for $10,930.22 million. | Pharmaceuticals: Generic | Chief Executive Officer | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Aquavit Pharmaceuticals, Inc.
 Aquavit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquavit Pharmaceuticals, Inc. operates as a healthcare company that discovers, develops, and commercializes therapeutic products. It offers pharmaceuticals, nutraceuticals, and biologics. The company was founded in October 2010 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Graduate Degree | |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| University of Utah | College/University | Masters Business Admin Graduate Degree Masters Business Admin Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Chairman | |
ORTHOsoft ULC
 ORTHOsoft ULC Packaged SoftwareTechnology Services Part of Zimmer Biomet Holdings, Inc., ORTHOsoft ULC is a Canadian medical software development company. The company is based in Montréal, Canada. Louis-Philippe Amiot has been the CEO of the company since 1995. ORTHOsoft ULC was acquired by Zimmer Biomet Holdings, Inc. on October 16, 2007 for $46.36 million. | Packaged Software | Director/Board Member | |
| Brigham Young University | College/University | Undergraduate Degree Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Graduate Degree | |
| Yale University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Utah State University | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| Utah Association of Certified Public Accountants | Corporate Officer/Principal Corporate Officer/Principal | ||
| LIPOCINE INC. | Pharmaceuticals: Major | Director of Finance/CFO Comptroller/Controller/Auditor | |
| University of Illinois | College/University | Undergraduate Degree Graduate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Chairman | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chairman | |
Sandoz Ltd.
 Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981. | Pharmaceuticals: Major | Director/Board Member | |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Chairman | |
| University of St. Gallen | College/University | Doctorate Degree | |
| ACUCELA INC | Pharmaceuticals: Major | Chief Executive Officer | |
| OBSEVA SA | Pharmaceuticals: Major | Chief Executive Officer | |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| The HENLEY College | College/University | Masters Business Admin | |
Biopartners GmbH
 Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 32 |
| Schweiz | 7 |
| Kanada | 4 |
| Deutschland | 3 |
| Vereinigtes Königreich | 3 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 171 |
| Corporate Officer/Principal | 85 |
| Chairman | 55 |
| Independent Dir/Board Member | 46 |
| Chief Executive Officer | 43 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Calvin Stiller | 38 |
| Michael Bonney | 32 |
| N. Coles | 30 |
| Max E. Link | 28 |
| Douglas Reed | 27 |
| Joseph Klein | 24 |
| Brian O'Callaghan | 20 |
| Jay Moyes | 18 |
| Peter G. Tombros | 18 |
| Jeffrey White | 14 |
| Robert E. Ward | 13 |
| Morgan Brown | 12 |
| Eric Kenneth Olson | 11 |
| George A. Singer | 10 |
| W. Karl Farnsworth | 9 |
- Börse
- Insiders
- Kevin J. Ontiveros
- Unternehmensverbindungen
